406 related articles for article (PubMed ID: 28666335)
1. A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin.
Bossi P; Cortinovis D; Fatigoni S; Cossu Rocca M; Fabi A; Seminara P; Ripamonti C; Alfieri S; Granata R; Bergamini C; Agustoni F; Bidoli P; Nolè F; Pessi MA; Macchi F; Michellini L; Montanaro F; Roila F
Ann Oncol; 2017 Oct; 28(10):2547-2551. PubMed ID: 28666335
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial.
Li X; Qin Y; Liu W; Zhou XY; Li YN; Wang LY
Integr Cancer Ther; 2018 Sep; 17(3):747-754. PubMed ID: 29417850
[TBL] [Abstract][Full Text] [Related]
3. Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial.
Crichton M; Marshall S; Isenring E; Lohning A; McCarthy AL; Molassiotis A; Bird R; Shannon C; Koh A; McPherson I; Marx W
J Acad Nutr Diet; 2024 Mar; 124(3):313-330.e6. PubMed ID: 37699474
[TBL] [Abstract][Full Text] [Related]
4. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients.
Ryan JL; Heckler CE; Roscoe JA; Dakhil SR; Kirshner J; Flynn PJ; Hickok JT; Morrow GR
Support Care Cancer; 2012 Jul; 20(7):1479-89. PubMed ID: 21818642
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting.
Zick SM; Ruffin MT; Lee J; Normolle DP; Siden R; Alrawi S; Brenner DE
Support Care Cancer; 2009 May; 17(5):563-72. PubMed ID: 19005687
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study.
Thamlikitkul L; Srimuninnimit V; Akewanlop C; Ithimakin S; Techawathanawanna S; Korphaisarn K; Chantharasamee J; Danchaivijitr P; Soparattanapaisarn N
Support Care Cancer; 2017 Feb; 25(2):459-464. PubMed ID: 27714530
[TBL] [Abstract][Full Text] [Related]
7. Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy.
Pillai AK; Sharma KK; Gupta YK; Bakhshi S
Pediatr Blood Cancer; 2011 Feb; 56(2):234-8. PubMed ID: 20842754
[TBL] [Abstract][Full Text] [Related]
8. Can ginger ameliorate chemotherapy-induced nausea? Protocol of a randomized double blind, placebo-controlled trial.
Marx W; McCarthy AL; Ried K; Vitetta L; McKavanagh D; Thomson D; Sali A; Isenring L
BMC Complement Altern Med; 2014 Apr; 14():134. PubMed ID: 24712653
[TBL] [Abstract][Full Text] [Related]
9. Does the Oral Administration of Ginger Reduce Chemotherapy-Induced Nausea and Vomiting?: A Meta-analysis of 10 Randomized Controlled Trials.
Chang WP; Peng YX
Cancer Nurs; 2019; 42(6):E14-E23. PubMed ID: 30299420
[TBL] [Abstract][Full Text] [Related]
10. Herbal medicine for the prevention of chemotherapy-induced nausea and vomiting in patients with advanced colorectal cancer: A prospective randomized controlled trial.
Wu Z; Fu X; Jing H; Huang W; Li X; Xiao C; Li Z; You F
J Ethnopharmacol; 2024 May; 325():117853. PubMed ID: 38341113
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial.
Grunberg SM; Rolski J; Strausz J; Aziz Z; Lane S; Russo MW; Wissel P; Guckert M; Wright O; Herrstedt J
Lancet Oncol; 2009 Jun; 10(6):549-58. PubMed ID: 19428297
[TBL] [Abstract][Full Text] [Related]
12. Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.
Lindley C; Goodin S; McCune J; Kane M; Amamoo MA; Shord S; Pham T; Yowell S; Laliberte K; Schell M; Bernard S; Socinski MA
Am J Clin Oncol; 2005 Jun; 28(3):270-6. PubMed ID: 15923800
[TBL] [Abstract][Full Text] [Related]
13. A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC).
Zhang L; Lu S; Feng J; Dechaphunkul A; Chang J; Wang D; Chessari S; Lanzarotti C; Jordan K; Aapro M
Ann Oncol; 2018 Feb; 29(2):452-458. PubMed ID: 29092012
[TBL] [Abstract][Full Text] [Related]
14. Ginger (Zingiber officinale) and chemotherapy-induced nausea and vomiting: a systematic literature review.
Marx WM; Teleni L; McCarthy AL; Vitetta L; McKavanagh D; Thomson D; Isenring E
Nutr Rev; 2013 Apr; 71(4):245-54. PubMed ID: 23550785
[TBL] [Abstract][Full Text] [Related]
15. Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trial.
Herrstedt J; Summers Y; Jordan K; von Pawel J; Jakobsen AH; Ewertz M; Chan S; Naik JD; Karthaus M; Dubey S; Davis R; Fox GM
Support Care Cancer; 2019 Jul; 27(7):2699-2705. PubMed ID: 30488222
[TBL] [Abstract][Full Text] [Related]
16. The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial.
Marx W; McCarthy AL; Ried K; McKavanagh D; Vitetta L; Sali A; Lohning A; Isenring E
Nutrients; 2017 Aug; 9(8):. PubMed ID: 28805667
[TBL] [Abstract][Full Text] [Related]
17. Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting.
Bossi P; Cortinovis D; Cossu Rocca M; Roila F; Seminara P; Fabi A; Canova S; Verri E; Fatigoni S; Iannace A; Macchi F; Ripamonti C
J Altern Complement Med; 2016 Jun; 22(6):486-8. PubMed ID: 27115042
[TBL] [Abstract][Full Text] [Related]
18. Validation of different personalized risk models of chemotherapy-induced nausea and vomiting: results of a randomized, double-blind, phase III trial of fosaprepitant for cancer patients treated with high-dose cisplatin.
Zhao Y; Zhao B; Chen G; Chen Y; Liao Z; Zhang H; Feng W; Li Y; Weng H; Li W; Zhou Y; Ren B; Lu Y; Chen J; Liu Z; Su Z; Wang W; Zhang L
Cancer Commun (Lond); 2023 Feb; 43(2):246-256. PubMed ID: 36545810
[TBL] [Abstract][Full Text] [Related]
19. Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial.
Pérol D; Provençal J; Hardy-Bessard AC; Coeffic D; Jacquin JP; Agostini C; Bachelot T; Guastalla JP; Pivot X; Martin JP; Bajard A; Ray-Coquard I
BMC Cancer; 2012 Dec; 12():603. PubMed ID: 23244208
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial.
Tsuji D; Suzuki K; Kawasaki Y; Goto K; Matsui R; Seki N; Hashimoto H; Hama T; Yamanaka T; Yamamoto N; Itoh K
Support Care Cancer; 2019 Mar; 27(3):1139-1147. PubMed ID: 30094732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
